HomeCompareECVTF vs JNJ

ECVTF vs JNJ: Dividend Comparison 2026

ECVTF yields 10.19% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ECVTF wins by $414.5K in total portfolio value
10 years
ECVTF
ECVTF
● Live price
10.19%
Share price
$17.88
Annual div
$1.82
5Y div CAGR
31.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$434.5K
Annual income
$194,842.90
Full ECVTF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ECVTF vs JNJ

📍 ECVTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodECVTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ECVTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ECVTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ECVTF
Annual income on $10K today (after 15% tax)
$865.83/yr
After 10yr DRIP, annual income (after tax)
$165,616.47/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ECVTF beats the other by $164,912.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ECVTF + JNJ for your $10,000?

ECVTF: 50%JNJ: 50%
100% JNJ50/50100% ECVTF
Portfolio after 10yr
$227.3K
Annual income
$97,835.34/yr
Blended yield
43.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ECVTF
No analyst data
Altman Z
7.1
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ECVTF buys
0
JNJ buys
0
No recent congressional trades found for ECVTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricECVTFJNJ
Forward yield10.19%3.36%
Annual dividend / share$1.82$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR31.7%5.8%
Portfolio after 10y$434.5K$20.0K
Annual income after 10y$194,842.90$827.78
Total dividends collected$383.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ECVTF vs JNJ ($10,000, DRIP)

YearECVTF PortfolioECVTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,042$1,341.53$10,676$355.77+$1.4KECVTF
2$14,873$1,988.31$11,407$389.39+$3.5KECVTF
3$18,937$3,022.70$12,198$426.53+$6.7KECVTF
4$24,999$4,737.03$13,056$467.62+$11.9KECVTF
5$34,446$7,697.19$13,987$513.12+$20.5KECVTF
6$49,912$13,054.24$14,998$563.56+$34.9KECVTF
7$76,687$23,281.68$16,098$619.52+$60.6KECVTF
8$126,084$44,028.80$17,295$681.69+$108.8KECVTF
9$224,010$89,099.69$18,599$750.82+$205.4KECVTF
10$434,533$194,842.90$20,022$827.78+$414.5KECVTF

ECVTF vs JNJ: Complete Analysis 2026

ECVTFStock

Economic Investment Trust Limited is a closed-ended equity mutual fund launched and managed by Burgundy Asset Management Ltd. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P/TSX Composite Index, MSCI World Index, and S&P 500 Index. Economic Investment Trust Limited was formed in January 28, 1927 and is domiciled in Canada.

Full ECVTF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ECVTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ECVTF vs SCHDECVTF vs JEPIECVTF vs OECVTF vs KOECVTF vs MAINECVTF vs ABBVECVTF vs MRKECVTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.